Can the effect of cold physical plasma-derived oxidants be transported via thiol group oxidation?

dc.bibliographicCitation.firstPage100086eng
dc.bibliographicCitation.volume14eng
dc.contributor.authorHeusler, Thea
dc.contributor.authorBruno, Giuliana
dc.contributor.authorBekeschus, Sander
dc.contributor.authorLackmann, Jan-Wilm
dc.contributor.authorWoedtke, Thomas von
dc.contributor.authorWende, Kristian
dc.date.accessioned2021-10-19T09:08:13Z
dc.date.available2021-10-19T09:08:13Z
dc.date.issued2019
dc.description.abstractPurpose: Intra- and intercellular redox-signaling processes where found responsible in various physiological and pathological processes with cellular thiol groups as important signal transducers. Using cold atmospheric plasma (CAP), a similar oxidation pattern of thiol groups can be achieved. Hence, it must be clarified which role extracellular thiol groups play in mediating CAP effects and whether or not the effects of short-lived reactive species can be preserved in a molecule like cysteine. Methods: Physiological buffer solutions containing the amino acid cysteine were treated by an MHz argon plasma jet with molecular gas admixtures (kINPen) and transferred to cultured human keratinocytes. Cell proliferation, migratory activity, and metabolism were investigated. High-resolution mass spectrometry was used to estimate the impact of plasma generated species on thiol groups. Results: While treated physiologic cysteine concentrations showed no impact on cell behavior, artificially high concentrations decreased proliferation, migration and lactate secretion. GSH levels inside cells were stabilized. Conclusion: Extracellular thiol groups scavenge plasma-generated species and form a multitude of covalent modifications. Unexpectedly, human keratinocytes show only small functional consequences for treated physiologic cysteine concentrations. Results for high concentrated cysteine solutions indicate an improved cytostatic/cytotoxic impact by plasma treatment suggesting a potential application as a “preserving agent” of the chemical energy of plasma-derived species. © 2019 The Authorseng
dc.description.versionpublishedVersioneng
dc.identifier.urihttps://oa.tib.eu/renate/handle/123456789/7040
dc.identifier.urihttps://doi.org/10.34657/6087
dc.language.isoengeng
dc.publisherAmsterdam [u.a.] : Elseviereng
dc.relation.doihttps://doi.org/10.1016/j.cpme.2019.100086
dc.relation.essn2212-8166
dc.relation.ispartofseriesClinical Plasma Medicine 14 (2019)eng
dc.rights.licenseCC BY-NC-ND 4.0 Unportedeng
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/eng
dc.subjectCysteine oxidationeng
dc.subjectPlasma medicineeng
dc.subjectRedox signalingeng
dc.subjectThiol switcheng
dc.subjectWound healingger
dc.subject.ddc610eng
dc.titleCan the effect of cold physical plasma-derived oxidants be transported via thiol group oxidation?eng
dc.typearticleeng
dc.typeTexteng
dcterms.bibliographicCitation.journalTitleClinical Plasma Medicineeng
tib.accessRightsopenAccesseng
wgl.contributorINPeng
wgl.subjectMedizin, Gesundheiteng
wgl.typeZeitschriftenartikeleng
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S2212816618300258-main.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format
Description:
Collections